Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02

This study was a second multicenter trial on childhood ALL by the Japan Childhood Leukemia Study Group (JACLS) to improve outcomes in non-T ALL. Between April 2002 and March 2008, 1138 children with non-T ALL were enrolled in the JACLS ALL-02 trial. Patients were stratified into three groups using a...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Blood Cancer J
المؤلفون الرئيسيون: Hasegawa, Daiichiro, Imamura, Toshihiko, Yumura-Yagi, Keiko, Takahashi, Yoshihiro, Usami, Ikuya, Suenobu, So-ichi, Nishimura, Shinichiro, Suzuki, Nobuhiro, Hashii, Yoshiko, Deguchi, Takao, Moriya-Saito, Akiko, Kato, Koji, Kosaka, Yoshiyuki, Hirayama, Masahiro, Iguchi, Akihiro, Kawasaki, Hirohide, Hori, Hiroki, Sato, Atsushi, Kudoh, Tooru, Nakahata, Tatsutoshi, Oda, Megumi, Hara, Junichi, Horibe, Keizo
التنسيق: Artigo
اللغة:Inglês
منشور في: Nature Publishing Group UK 2020
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046744/
https://ncbi.nlm.nih.gov/pubmed/32107374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-0287-4
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة